 |
 |
 |
 |
 |
 |
 |
 |
Management
Management
Management is Everything
The GeNOsys management team is made up of seasoned professionals who:
- Have strong business skills and a demonstrated ability to complete the R&D process and take the company's products to market.
- Have strong, professional management and medical skills and the specialized knowledge required.
- Have the know how to complete the FDA approval process and manage the business plan.
- Understand the economics of the industry, the pharmaceutical and medical device business model, and most important recognize the reasons for the failure of others.
- Have the leadership skills necessary to inspire loyalty and motivate the team.
- Know that the infrastructure, policies, and procedures that we establish at the company's foundation will set the stage for its enduring success.
The Team
John W. "Randy" Miller
Chairman and Chief Executive Officer
With more than three decades of research, development and engineering experience, Mr. Miller brings a considerable career and body of knowledge and ability to GeNOsys with demonstrable success in research, development and bringing to market of related gaseous pharmaceutical products and medical device technology. Prior to joining GeNOsys Mr. Miller was the co-founder and CEO of Pulmonox Research & Development and Pulmonox Medical Corporation where over the course of a decade Mr. Miller pioneered FDA approved inhaled nitric oxide therapy and engineered delivery system devices. At Pulmonox his expertise reached beyond the research lab to engineering, where he has had success in conceiving, engineering and bringing to market US patented inhaled nitric oxide therapy medical devices. Mr. Miller received training at Union Carbide from 1983 to 1990 where he became a Driox, cryogenic engineer and participated in design and implementation of more than 50 cryogenic research and development projects that included breathing oxygen for the F-14 Tomcat US military fighter jet, heavy oil recovery and fire suppression in the oil and gas industry, development of clean room environmental systems for micro chip manufacture, hospital oxygen delivery systems, and electron microscope cooling applications. Mr. Miller's research was an essential component at Equinox, a veterinary company, where Mr. Miller and his colleagues established the use of nitric oxide in the treatment of capillary stress failure in horses for the racing industry. Mr. Miller is a recognized contributor in the gaseous pharmaceutical and engineered medical device industry, as an author or contributor to articles and papers in industrial, medical and technical research and application publications. Mr. Miller holds a BS in education and business from Brigham Young University and numerous technical and medical certifications such as: Q.A. FDA Quality Assurance from Noblitt & Rueland, and NAIT Driox Cryogenic Engineer certification from Union Carbide.
Keith L. Merrell
Chief Financial Officer
With more than 28 years of accounting experience managing both public and private enterprises Mr. Merrell brings a significant scope and understanding necessary to facilitate the R&D and operational aspects of his position. Prior to joining GeNOsys Mr. Merrell served as Chief Financial Officer and Comptroller of Specialized Health Products International, Inc. a company that specialized in the manufacture of safety medical devices. Mr. Merrell has a depth of experience essential to the growth of the company from his role as the Vice President of Western Operations for Michelex where he was responsible for bringing on-line an injection molding facility, on time and under budget. As the Director of Finance at The Duplication Group his skills were once again to plan and implement the then new technology of compact disc manufacture. Mr. Merrell has proven experience with development stage private and public company management and oversight and in growing the same through mergers and acquisition. Mr. Merrell earned a Bachelor of Science in Accounting from Arizona State University
Dr. Stephen D. Minton, M.D.
Chief Medical Officer
As the Chief of Neonatology at Utah Valley Regional Medical Center and the Intermountain Health Care Urban South Medical Director of Newborn Services, Dr. Minton's commitment to his profession is nationally recognized. In 1979 Dr. Minton opened the first non-university associated regional newborn intensive care unit in the United States and has since grown his practice to be recognized by Vermont Oxford as "the most family-centered care Neonatal Intensive Care Unit (NICU) in the nation." Dr. Minton has been nationally recognized for ongoing research, showing his commitment to best care for infants. Dr. Minton heads a team of physicians and health care professionals who have helped make high frequency oscillatory ventilation a common practice in NICU's across the entire United States. As a demonstration of his peers acceptance for his clinical ability Dr. Minton is the recipient of Intermountain Health Care's Physician of Excellence of Women's and Children's Services; NICU Guardian Angel Award from the Celebration of Health Foundation and the prestigious Osler Cloak Award for Excellence in Caring and Curing. As a Diplomat in the American Academy of Pediatrics with a subspecialty in Neonatal-Perinatal Medicine and further as a Diplomat with the American Board of Pediatrics, Dr. Minton is uniquely qualified to direct the medical research and implementation of the Company's nitric oxide gas pharmacological technology and gas generating devices. As a practicing physician for 31 years with a specialty and intense interest in the care of the critically ill new born, Dr. Minton's expert knowledge and the scope of his understanding of the efficacy of the Company's research, products and devices is unparalleled. From his appointment as Chief Resident-Pediatrics during his initial medical training to his current tenure as Chief of Neonatology, Dr. Minton has demonstrated not only medical prowess but the unique ability to manage people and run a business within a very structured environment. Dr. Minton is a widely published and a recognized expert in neonatal care using nitric oxide gas inhalation therapy. He has authored, too numerous for mention in this venue, peer reviewed and non peer reviewed publications and has presented his works around the world. Dr. Minton is the recipient of research grants and various financial awards to further his vital research and work. He has the respect of his peers and employers as a result of added administrative duties from acting as the Medical Director of the Cincinnati Free Clinic in 1972 to an appointment as a Member of the National Faculty, of the Neonatal Resuscitation Program of the American Academy of Pediatrics and American Heart Association. Dr. Minton earned a Bachelor of Science degree from the University of Cincinnati in 1967 and a Doctor of Medicine from the University of Cincinnati School of Medicine, where he was Phi Lambda Upsilon, Phi Kappa Epsilon and Alpha Omega Alpha as a Medical Scholar.
Chad Young
Executive Vice President
Mr. Young joined GeNOsys in 2010 bringing with him broad management experience ranging from small, entrepreneurial businesses to global, multi-industry organizations. He has worked extensively in organizational design and change management. He also directed business activities in the areas of executive compensation, performance management and succession planning prior to working at GeNOsys. Most recently, Mr. Young was Director of Global Talent Development for Textron Inc. which is ranked 173rd on the Fortune 500 list of largest U.S. companies. He holds a master’s degree in business from Brigham Young University’s Marriott School of Management.
Board of Directors, Advisory & Scientific Board
John P. Livingstone, Ed.D.
Director
Dr. Livingstone, a practicing psychologist, has served as an educator both in Canada and the United States, and is currently a professor at Brigham Young University. Dr. Livingstone has contributed to and published a number books, papers and articles. His work has earned recognition from his peers for his distinguished service. Dr. Livingstone earned a BSc. in Biology-Chemistry from the University of Alberta, a Master's Degree from the University of Regina and an Ed.D. from Brigham Young University.